Costs and Consequences of Three Common Orthopedic Procedures on the Upper Extremity

October 20, 2020 updated by: Schulthess Klinik

Costs and Consequences of Three Common Orthopedic Procedures on the Upper Extremity - Health Economic Investigation (Cost-effectiveness and Cost-utility Analyses) With Before and After Surgery Comparison

This study compares costs and effectiveness / utility of three common orthopedic surgeries in shoulder and hand from the perspective of the Swiss health system and the clinic.

The cost of health care is continuously rising, making economic considerations part of the decision process, in particular for the allocation of available resources. However, cost-effectiveness and cost-utility studies of interventions in the upper extremities are rare. The purpose of this study is to gain more information and to provide a basis for the decision process.

Study Overview

Detailed Description

Among various recognized methods used to assess the benefits and value of medical services, cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) are taking an increasingly important role. Over recent years, economic evaluations gained interest in orthopedics, suggesting the inclusion of economic factors in addition to traditional outcome measures in the evaluation of surgical interventions.

This is a prospective mono-center observational study involving three independent patient groups (Total shoulder prosthesis for arthritis (TSA), Arthroscopic repair of rotator cuff tears (RCR), Trapeziectomy for Trapeziometacarpal Osteoarthritis (TMC OA)) of 150 patients each. Before-and-after comparisons will be made: Cost-effectiveness and cost-utility data collected post-operatively up to one (TMC OA) and two years (TSA and RCR) will be compared with those collected up to one year pre-operatively. Eligible patients unwilling to receive surgery will be followed-up for one and two years, respectively, to allow for a parallel comparison group.

Study Type

Observational

Enrollment (Actual)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8008
        • Schulthess Klinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • Patients with shoulder arthritis and/or rotator cuff tear arthropathy indicated for total shoulder prosthesis (TSA)
  • Patients with rotator cuff tear indicated for arthroscopic rotator cuff reconstruction (RCR)
  • Trapeziometacarpal osteoarthritis (TMC OA) patients indicated for resection interposition suspension arthroplasty

Description

Inclusion Criteria:

  • Male and female patient aged 18 years and over
  • Patient willing and able to give written informed consent to participate in the study including all pre-surgical and post-surgical follow-up examinations
  • Patient authorizing that their health insurance be contacted to provide health-related costs for the purpose of this study

Specific inclusion Criteria:

TSA:

  • patients diagnosed with primary or secondary glenohumeral arthritis and/or rotator cuff tear arthropathy
  • indicated for treatment with a total anatomic or reverse shoulder prosthesis or

RCR:

  • patients diagnosed with partial or complete rotator cuff tear
  • indicated for rotator cuff reconstruction by arthroscopy

or

TMC OA:

  • patients diagnosed with TMC OA
  • indicated for surgical treatment by resection interposition suspension arthroplasty of the TMC joint

Exclusion Criteria:

  • General medical contraindication to surgery
  • Revision operations
  • Known hypersensitivity to the materials used
  • Tumour / malignoma
  • Addiction or other disorders (e.g. neuromuscular, psychiatric or metabolic disorder) that would preclude accurate evaluation
  • Recent history of substance abuse
  • Legal incompetence
  • Pregnant women
  • Participation in any other medical device or medicinal product study within the previous months that could influence the results of the present study

Specific exclusion Criteria:

  • Other joints operated in the same session, except arthrodesis of the metacarpophalangeal (MCP) I joint
  • Patients with rheumatoid arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Operated TSA Patients
Patients with glenohumeral arthritis and/or rotator cuff tear arthropathy who were operated and received a total shoulder prosthesis
Total shoulder prosthesis: Anatomic or reverse total shoulder replacement is a well-standardized procedure usually performed under general anesthesia with the patient in a beach-chair position
Non-operated TSA Patients
TSA-patients, indicated for treatment with a total shoulder prosthesis, who decided not to operate
Operated RCR Patients
Patients with rotator cuff tear who were operated and received a rotator cuff reconstruction by arthroscopy
Arthroscopic rotator cuff tear reconstruction. The shoulder arthroscopy is performed according to internal and international standard procedure with patients positioned in beach-chair position under general anesthesia.
Non-operated RCR Patients
RCR-patients, indicated for rotator cuff reconstruction by arthroscopy, who decided not to operate
Operated TMC OA Patients
Patients with trapeziometacarpal (TMC) osteoarthritis who were operated and received a resection interposition suspension arthroplasty of the TMC joint

One of five surgical techniques can be used in this study, as routinely performed by each surgeon:

  1. RISA with FCR-Ligament (flexor carpi radialis ligament) modified according to Epping
  2. RISA with FCR-Ligament modified according to Weilby
  3. RISA with APL-Ligament (abductor pollicis longus ligament)
  4. RISA with Graftjacket modified according to Weilby
  5. Resection arthroplasty
Non-operated TMC OA Patients
TMC OA-patients, indicated for surgical treatment (resection interposition suspension arthroplasty), who decided not to operate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness and cost-utility of the targeted interventions
Time Frame: Change from 1 year before OP at 1 (TMC OA) or 2 (RCR, TSA) years post OP (/ after enrollment for non-operated patients)

To calculate the cost-effectiveness and cost-utility of the targeted interventions we will assess the following parameters before and after surgery:

  • Health-related costs which include all direct and indirect costs before and after surgery (productivity via work status/salary and Work Productivity and Activity Impairment Questionnaire WPAI)
  • Quality-Adjusted Life years (QALYs)
  • Incremental Cost Effectiveness Ratio (ICER)
Change from 1 year before OP at 1 (TMC OA) or 2 (RCR, TSA) years post OP (/ after enrollment for non-operated patients)
Change in quality of life
Time Frame: preOP, immediately preOP, 2 weeks, 3, 6, 12 months postOP respectively 6 and 12 months after enrollment for non-operated patients
Quality of life (utilities) derived using EuroQoL EQ-5D-5L. The primary analysis will investigate the change between immediately before and one year after surgery.
preOP, immediately preOP, 2 weeks, 3, 6, 12 months postOP respectively 6 and 12 months after enrollment for non-operated patients

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quality of life in TSA- and RCR-Patients after 2 years
Time Frame: 2 years postOP (/ after enrollment for non-operated patients)
Quality of life (utilities) derived using EQ-5D-5L
2 years postOP (/ after enrollment for non-operated patients)
Complications
Time Frame: From enrollment up to 1 or 2 years after surgery
Patient-level risk of intervention-related complications (during non-operative management, intra-operative, post-operative including events leading to revision surgeries).
From enrollment up to 1 or 2 years after surgery
Local imaging Parameters (assessed from MRT, ultrasound, radiographs)
Time Frame: TSA: preOP, 6 months, 1 and 2 years postOP, RCR: preOP, 6 months postOP, TMC OA: preOP

TSA preOP:

  • Status of the rotator cuff (intact / partial rupture)
  • Supraspinatus muscle atrophy
  • Amount of fatty infiltration in the rotator cuff muscles
  • Acromiohumeral distance
  • Severity of arthrosis

TSA postOP:

  • Head position with respect to glenoid
  • Occurrence of osteolysis and migration
  • Cortical bone resorption (when a shaft is implanted)
  • Status of the Tuberculum Majus

RCR preOP:

  • Location and extent of the injury of the rotator cuff (partial / complete rupture)
  • Amount of fatty infiltration in the rotator cuff muscles
  • Extend of tendon retraction
  • Signs of tendon degeneration

RCR postOP:

  • Position of the anchors
  • Postoperative tissue growth

TMC OA preOP:

  • Stage of Osteoarthritis
  • Occurrence of articular chondrocalcinosis
  • Involvement of the scapho-trapezio-trapezoidal (STT) joint
  • Distance between the scaphoid and the metacarpal
TSA: preOP, 6 months, 1 and 2 years postOP, RCR: preOP, 6 months postOP, TMC OA: preOP
Change of Constant (Murley) score (CS) due to surgery in TSA- and RCR-patients
Time Frame: preOP, immediately preOP, 3, 6 months postOP. TSA additionally: 12, 24 months postOP

The Constant (Murley) score is possibly the most commonly used tool for assessment of shoulder function. The physician asks and documents answers to Quality of life questions (pain and activity of daily living, ability to work, sleep, sports and leisure) and certain clinical parameters (active range of motion, abduction strength). The different scales will be summed and normalized to 0 = worst to 100 = best. A German version is available for clinical use.

With the CS we can assess the change and gain in functional shoulder outcome.

preOP, immediately preOP, 3, 6 months postOP. TSA additionally: 12, 24 months postOP
Change of range of motion due to surgery in TSA- and RCR-patients
Time Frame: preOP, immediately preOP, 3, 6 months postOP. TSA additionally: 12, 24 months postOP

Additional to th Constant score we assess the

  • passive abduction
  • passive elevation
  • active and passive external rotation by 0°
  • active and passive external-internal rotation by 90°
preOP, immediately preOP, 3, 6 months postOP. TSA additionally: 12, 24 months postOP
Change of Kapandji index and grip + key pinch strength due to surgery in TMC OA-patients
Time Frame: preOP, immediately preOP, 3, 6, 12 months postOP

The ability to oppose the thumb of both hands will be quantified using the Kapandji index. The flexion/extension of the metacarpo-phalangeal (MCP) and inter-phalangeal (IP) joint of the affected and contralateral thumb will be measured with an electrical Goniometer (ELINK, Biometrics Ltd., Gwent, UK).

Grip strength as well as key pinch strength of both hands will be measured with the help of an electrical dynamometer and pinch gauge (ELINK, Biometrics Ltd., Gwent, UK). Three records will be taken and the mean value will be taken for analyses. The standardized testing position as recommended by the American Society of Hand Therapists will be used.

preOP, immediately preOP, 3, 6, 12 months postOP
Change of Shoulder Pain and Disability Index (SPADI) during study participation in TSA-patients
Time Frame: preOP, immediately preOP, 3, 6, 12, 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
The Shoulder Pain and Disability Index (SPADI) is a short, self-administered questionnaire that provides an item scoring by a visual analogue scale (VAS) from 0 (no pain/no difficulty, i.e. best) to 11 (worst pain imaginable/so difficult required help, i.e. worst). Five items assess pain and 8 items disability of the arm (function). The unweighted means of the 5 pain and the 8 function items will be transformed into the scale from 0 (=worst) to 100 (=best) for both scales and are used to determine pain and function scores. The average of these two scores then gives the total SPADI score. A validated German version is available.
preOP, immediately preOP, 3, 6, 12, 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
Change in Oxford Shoulder Score (OSS) during study participation in RCR-patients
Time Frame: preOP, immediately preOP, 3, 6, 12 and 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
The OSS is a condition-specific questionnaire developed for patients with a degenerative or inflammatory state of the shoulder. It contains 12 items to be answered by the patient independently, which deal with pain (degree, time point) and possible handicaps in private and professional life. There are five categories of response for every question, corresponding to a score ranging from 0 to 4. Scores are combined to give a single score, with a range from 0 (worst outcome) to 48 (best outcome). The score can also be standardized from 0 to 100 (best) for comparison with other outcome instruments. A German version of this questionnaire is available and it is suitable for patient-based outcome after rotator cuff repair.
preOP, immediately preOP, 3, 6, 12 and 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
Change in Michigan Hand Outcomes Questionnaire (brief MHQ) during study participation in TMC OA-patients
Time Frame: preOP, immediately preOP, 3, 6, 12 months postOP; respectively 6 and 12 months after enrollment for non-operated patients

The Michigan Hand Outcomes Questionnaire MHQ was specifically designed to measure health state domains important to patients with hand disorders. In contrast to the widely applied DASH, the MHQ seems to be more sensitive to functional changes in hand patients. Compared to the DASH and Patient Evaluation Measure, the MHQ shows the highest correlation in finger patients with grip strength and range of motion.

In this study we will use a short version of the MHQ that includes only 12 questions for patients with acute or chronic disorders of the hand. The answers are rated on a 5-point Likert scale and scores are normalized on a scale of 0 to 100. The brief MHQ demonstrated an excellent test-retest reliability.

preOP, immediately preOP, 3, 6, 12 months postOP; respectively 6 and 12 months after enrollment for non-operated patients
Change in Disability of the Arm, Shoulder and Hand questionnaire (QuickDASH) during study participation in TSA- and TMC OA-patients
Time Frame: TMC OA + TSA: preOP, immediately preOP, 3, 6, 12 months postOP. TSA additionally: 24 months. 6, 12 and 24 months after enrollment for non-operated patients.
The Disability of the Arm, Shoulder and Hand questionnaire (DASH) is a comprehensive self-administered questionnaire about symptoms and functioning of the entire upper extremity. The DASH enquires about the ability to perform simple and complex activities of daily living (ADL) that are commonly performed with either one or both arms. The total score is derived from the unweighted mean of 30 items, of which at least 27 have to be answered. The QuickDASH is a more efficient version of the DASH outcome measure that appears to retain its measurement properties. It contains eleven items and is similar with regard to scores and properties to the full DASH. A validated full-length German version is available that can be used in the shortened version.
TMC OA + TSA: preOP, immediately preOP, 3, 6, 12 months postOP. TSA additionally: 24 months. 6, 12 and 24 months after enrollment for non-operated patients.
Change in Subjective shoulder value (SVV) during study participation in TSA- and RCR-patients
Time Frame: RCR + TSA: preOP, immediately preOP, 3, 6, 12, 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
The Subjective Shoulder Value (SSV) is based on a single question that is answered subjectively by the patients. The formulation of this question is: "What is the overall percent value of your shoulder if a completely normal shoulder represents 100%?" It is an easily administered measure of shoulder function.
RCR + TSA: preOP, immediately preOP, 3, 6, 12, 24 months postOP; respectively 6, 12 and 24 months after enrollment for non-operated patients
Change in general health during study participation
Time Frame: preOP, immediately preOP, 3, 6, 12 months postOP. TSA + RCR additionally: 24 months postOP; ; respectively 6, 12 and 24 months after enrollment for non-operated patients

The outcome measure "general health" is a composite of these three questions:

  • patients will be asked to report their general health status on a visual analog scale from 0 (worst possible health) to 100 (best possible health) using the EQ-5D-5L instrument.
  • In addition, patients will be asked to assess their current state of health related to the operated shoulder or hand at follow-up compared to the state before surgery. This so-called 'transition' question has the possible answers 'much worse', 'slightly worse', 'equal', 'slightly better', and 'much better'.
  • A similar question will be asked regarding their perceived change in quality of life at follow-up compared to the state before surgery.
preOP, immediately preOP, 3, 6, 12 months postOP. TSA + RCR additionally: 24 months postOP; ; respectively 6, 12 and 24 months after enrollment for non-operated patients
Change in level of satisfaction during study participation
Time Frame: preOP, immediately preOP, 3, 6, 12 months postOP. TSA + RCR additionally: 24 months postOP. ; 6, 12 and 24 months after enrollment for non-operated patients

The outcome measure "level of satisfaction" is a composite of these two questions:

  • Patients are asked to rate their level of satisfaction, with the help of a numeric rating scale (NRS: 0-10), in terms of how the outcome met up to their preoperative expectations.
  • Finally, they will be asked whether - with their current knowledge of the outcome - they would again choose the operation if they found themselves in similar circumstances to those which prevailed preoperatively.
preOP, immediately preOP, 3, 6, 12 months postOP. TSA + RCR additionally: 24 months postOP. ; 6, 12 and 24 months after enrollment for non-operated patients

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthias P Flury, Dr. med., Schulthess Klinik
  • Study Director: Laurent Audigé, DVM PhD, Schulthess Klinik

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2013

Primary Completion (ACTUAL)

June 7, 2019

Study Completion (ACTUAL)

October 12, 2020

Study Registration Dates

First Submitted

September 17, 2013

First Submitted That Met QC Criteria

September 26, 2013

First Posted (ESTIMATE)

October 1, 2013

Study Record Updates

Last Update Posted (ACTUAL)

October 22, 2020

Last Update Submitted That Met QC Criteria

October 20, 2020

Last Verified

October 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tear

Clinical Trials on Operated TSA Patients

Subscribe